Part Number
Part Number:
NSN:
NIIN:
Item Name:
SODIUM HYALURONATE INJECTION
Definition:
CAGE Information
| Code | Company |
|---|---|
| 93703 | PHARMACIA & UPJOHN COMPANY |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 14.000 KILOGRAMS PER CUBIC DECIMETER SODIUM HYALURONATE PER MILLILITER |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| CSGS | ADMINISTRATION | INTRAOCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | HEALON GV 14MG PER ML 0.85 ML GLASS SYRINGE WITH 27 GAGE CANNULA |
| FEAT | SPECIAL FEATURES | IN DISPOSABLE GLASS SYRINGE WITH STERILE SINGLE USE 27 GAGE CANNULA; REFRIGERATED HEALON GV SHOULD BE HELD AT ROOM TEMP FOR APPROX 30 MINUTES BEFORE USE; PROTECT FROM FREEZING AND EXPOSURE TO LIGHT; FOR USE IN ANTERIOR SEGMENT OPHTHALMIC SURGICAL PROCEDURES |
| CQCT | PRIMARY CONTAINER TYPE | SYRINGE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 0.850 MILLILITERS |